BiotechTube
Home/Yarrow Bioscience/Rebecca Frey
RF

Rebecca Frey

President and Chief Executive Officer

Yarrow Bioscience

Therapeutic Areas

Autoimmune DiseasesEndocrinology

Yarrow Bioscience Pipeline

DrugIndicationPhase
YB-101 (GS-098)Graves' DiseasePhase 1b/2b

Leadership Team at Yarrow Bioscience

DD
David Domzalski
President and Chief Executive Officer of VYNE Therapeutics (pre-merger)
MZ
Matthew Zola
Author of Press Release
View full Yarrow Bioscience profile